Additionally, METTL3 could promote angiogenesis and metastasis in gastric cancer (GC) and bladder cancer through regulating m6A and mRNA stability of hepatoma-derived growth factor (HDGF), tyrosine kinase endothelial (TEK) and VEGFA, respectively (25, 32). Here, HDGF is linked to urinary bladder cancer.